Nuvalent (NUVL) Operating Expenses (2020 - 2026)
Nuvalent (NUVL) posted Operating Expenses of $119.4 million for Q1 2026, up 16.8% on a QoQ basis from $102.2 million in Q4 2025, and up 25.94% year-over-year from $94.8 million in Q1 2025.
Nuvalent (NUVL) Operating Expenses (2020 - 2026) Analysis & Trends
Nuvalent's Operating Expenses history runs 7 years deep, the most recent figure standing at $119.4 million for Q1 2026.
- Quarterly Operating Expenses rose 25.94% year-over-year to $119.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $337.7 million (up 2907.32% YoY) and the FY2025 annual result came in at $414.3 million, up 2265.98% from the prior year.
- Operating Expenses was $119.4 million for Q1 2026 at Nuvalent, up from $102.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $119.4 million in Q1 2026 and bottomed at -$176.6 million in Q4 2024.
- A 5-year average of $23.2 million and a median of $30.2 million in 2023 frame the typical range for Operating Expenses.
- Peak annual rise in Operating Expenses reached 187.05% in 2022, while the deepest fall reached 385.92% in 2022.
- Nuvalent's Operating Expenses stood at -$49.7 million in 2022, then sank by 88.71% to -$93.8 million in 2023, then slumped by 88.3% to -$176.6 million in 2024, then jumped by 157.9% to $102.2 million in 2025, then advanced by 16.8% to $119.4 million in 2026.
- Business Quant data shows NUVL's Operating Expenses at $119.4 million in Q1 2026, $102.2 million in Q4 2025, and $11.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 119.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.41 Mn |
| Dec 31, 2025 | 102.23 Mn |
| Sep 30, 2025 | 11.46 Mn |
| Jun 30, 2025 | 104.57 Mn |
| Mar 31, 2025 | 94.81 Mn |
| Dec 31, 2024 | -176.56 Mn |
| Sep 30, 2024 | 4.57 Mn |
| Jun 30, 2024 | 65.15 Mn |
| Mar 31, 2024 | 52.59 Mn |
| Dec 31, 2023 | -93.76 Mn |
| Sep 30, 2023 | 38.78 Mn |
| Jun 30, 2023 | 34.06 Mn |
| Mar 31, 2023 | 30.21 Mn |
| Dec 31, 2022 | -49.69 Mn |
| Sep 30, 2022 | 20.39 Mn |
| Jun 30, 2022 | 18.73 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 17.38 Mn |
| Sep 30, 2021 | 12.43 Mn |
| Jun 30, 2021 | 9.85 Mn |